DexCom (DXCM)
(Delayed Data from NSDQ)
$110.91 USD
-1.58 (-1.40%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $110.96 +0.05 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Brokerage Reports
0 items in cart
DexCom, Inc. [DXCM]
Reports for Purchase
Showing records 201 - 220 ( 413 total )
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Q1 sales ahead, gross profit light chasm crossing more expensive than thought?
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Topline Beat and Solid Fundamentals Should More Than Offset Temporary Noise; Reit. OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Feltl CGM Project: Historical survey of 2,004 CGM users (2007 - present)
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
1Q16 MedTech Preview: Stable Trends; Prefer the Oversold Names With Solid Fundamentals
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 Results and G5 Mobile launch impressive; stock still too rich for our blood
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Take Advantage of the Pullback As DXCM''s Growth Outlook Remains Robust; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Survey of Diabetes Educators Very Positive for DXCM''s Growth Outlook; Suggests Recent Concerns Misplaced; Reiterate OUTPERFORM on DXCM
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Proprietary Survey of Diabetes Educators Suggests Patients Prefer Tandem''s Insulin Pumps; Reiterate OUTPERFORM on TNDM shares
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
Company: DexCom, Inc.
Industry: Medical - Instruments
Q4 2015 Revenue Preannouncement Above Estimates, Reiterate SELL
Provider: Feltl & Company
Analyst: HAYNOR B
Company: DexCom, Inc.
Industry: Medical - Instruments
Pre-Announces Solid Topline Beat And Issues Revenue Guidance Ahead of Expectations; Reiterate
Provider: WEDBUSH SECURITIES INC.
Company: DexCom, Inc.
Industry: Medical - Instruments
MedTech 2016 Outlook: Risk/Reward Looks Attractive
Provider: WEDBUSH SECURITIES INC.